Insider Trading & Ownership - SCHMIDT ERIC THOMAS

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for SCHMIDT ERIC THOMAS
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-03-15
Sale
2022-03-17
5:58 pm
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
11,469$7.6337$87,5511,253,141
(Indirect
Direct)
View
2021-03-15
Sale
2021-03-17
5:00 pm
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
8,053$38.23$307,8891,223,826
(Indirect
Direct)
View
2021-01-14
Sale
2021-01-19
4:31 pm
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
30,000$31.52$945,4691,231,511
(Indirect
Direct)
View
2020-11-16
Sale
2020-11-18
4:36 pm
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
15,000$32.88$493,1461,261,511
(Indirect
Direct)
View
2020-10-15
Sale
2020-10-16
6:55 pm
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
15,000$40.49$607,3921,276,511
(Indirect
Direct)
View
2020-09-21
Sale
2020-09-22
4:48 pm
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
15,000$35.3$529,5451,291,741
(Indirect
Direct)
View
2020-03-16
Sale
2020-03-18
4:32 pm
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
5,450$19.73$107,5081,275,501
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-08
Option Award
2023-06-12
4:14 pm
N/A
2033-06-07
Revolution Medicines Inc.RVMDSCHMIDT ERIC THOMAS
Director
23,600$039,651
(Direct)
View
2023-05-25
Option Award
2023-05-30
5:09 pm
2023-03-16
2032-12-16
RELMADA THERAPEUTICS INC.RLMDSCHMIDT ERIC THOMAS
Director
92,958$0150,000
(Direct)
View
2023-03-22
Option Award
2023-03-24
8:17 pm
N/A
2033-03-22
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
990,832$02,447,772
(Direct)
View
2023-03-14
Tax Withholding
2023-03-16
5:08 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
35,879$5.471,456,940
(Direct)
View
2022-12-16
Option Award
2022-12-20
5:33 pm
2023-03-16
2032-12-16
RELMADA THERAPEUTICS INC.RLMDSCHMIDT ERIC THOMAS
Director
57,042$057,042
(Direct)
View
2022-06-16
Option Award
2022-06-17
5:04 pm
N/A
2032-06-15
Revolution Medicines Inc.RVMDSCHMIDT ERIC THOMAS
Director
23,600$034,451
(Direct)
View
2022-05-25
Option Award
2022-05-26
6:41 pm
2022-03-17
2031-12-17
RELMADA THERAPEUTICS INC.RLMDSCHMIDT ERIC THOMAS
Director
91,235$0150,000
(Direct)
View
2022-03-23
Option Award
2022-03-25
5:49 pm
N/A
2032-03-23
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
605,947$01,859,088
(Direct)
View
2021-12-17
Option Award
2021-12-21
9:31 pm
2022-03-17
2031-12-17
RELMADA THERAPEUTICS INC.RLMDSCHMIDT ERIC THOMAS
Director
58,765$058,765
(Direct)
View
2021-06-22
Option Award
2021-06-24
5:17 pm
N/A
2031-06-21
Revolution Medicines Inc.RVMDSCHMIDT ERIC THOMAS
Director
16,276$023,510
(Direct)
View
2021-05-24
Exercise
2021-05-26
08:00 am
N/A
N/A
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
14,897$18.221,358,292
(Direct)
View
2021-05-24
Exercise
2021-05-26
08:00 am
N/A
2030-03-18
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
14,897$01,358,292
(Direct)
View
2021-03-26
Option Award
2021-03-30
4:51 pm
N/A
2031-03-26
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
117,231$01,341,057
(Direct)
View
2021-01-07
Option Award
2021-01-11
4:10 pm
2021-04-07
2031-01-07
RELMADA THERAPEUTICS INC.RLMDSCHMIDT ERIC THOMAS
Director
100,000$0100,000
(Direct)
View
2020-06-17
Option Award
2020-06-19
3:33 pm
N/A
2030-06-16
Revolution Medicines Inc.RVMDSCHMIDT ERIC THOMAS
Director
32,552$032,552
(Direct)
View
2020-04-09
Exercise
2020-04-09
4:37 pm
2019-05-14
2024-05-14
RELMADA THERAPEUTICS INC.RLMDSCHMIDT ERIC THOMAS
Director
12,500$9100,000
(Direct)
View
2020-04-09
Exercise
2020-04-09
4:37 pm
2018-12-03
2023-12-03
RELMADA THERAPEUTICS INC.RLMDSCHMIDT ERIC THOMAS
Director
32,500$6100,000
(Direct)
View
2020-03-18
Option Award
2020-03-20
4:36 pm
N/A
2030-03-17
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
140,400$01,415,901
(Direct)
View
2020-02-20
Other
2020-02-24
5:14 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
237,155$25.31,517,157
(Indirect)
View

Ownership
2019-12-23
5:02 pm
N/A
N/A
RELMADA THERAPEUTICS INC.RLMDSCHMIDT ERIC THOMAS
Director
0$0300,000
(Direct)
View